Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

Figure 1

The epidemiological findings regarding GBS diagnosis and associated antecedent event. (a) Number of patients with GBS and SARS-CoV2-related antecedent event according to the year of diagnosis. (b, c) Proportion of patients with GBS according to the associated antecedent event (b) and electrodiagnosis (c) before and after the SARS-CoV-2 pandemic outbreak. AIDP: acute inflammatory demyelinating polyradiculoneuropathy; AMAN: acute motor axonal neuropathy; AMSAN: acute motor and sensory axonal neuropathy; GBS: Guillain-Barré syndrome; URTI: upper respiratory tract infection.

(a)

(b)

(c)